» Articles » PMID: 12134946

Are MDCK Cells Transfected with the Human MRP2 Gene a Good Model of the Human Intestinal Mucosa?

Overview
Journal Pharm Res
Specialties Pharmacology
Pharmacy
Date 2002 Jul 24
PMID 12134946
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate whether Madin-Darby canine kidney cells transfected with the human MRP2 gene (MDCK-MRP2) are a good model of the human intestinal mucosa.

Methods: MRP2 expression in Caco-2 cells was compared with the expression of this efflux transporter in MDCK-wild type (MDCK-WT) and MDCK-MRP2 cells using Western blotting methods. The polarized efflux activities of MRP2 in the MDCK-MRP2, MDCK-WT. MDCK cells transfected with the human MDR1 gene (MDCK-MDR1), and Caco-2 cells were compared using vinblastine as a substrate. Apparent Michaelis-Menten constants (K(M), Vmax) for the efflux of vinblastine in Caco-2 and MDCK-MRP2 cells were determined in the presence of GF120918 (2 microM), which inhibits P-glycoprotein but does not affect MRP2. Apparent inhibitory constants (K(I)) of known substrates/inhibitors of MRP2 were determined by measuring their effects on the efflux of vinblastine in these cell lines.

Results: MDCK-MRP2 cells expressed higher levels of MRP2 than MDCK-WT and Caco-2 cells as measured by Western blotting technique. Two isoforms of MRP2 expressed in Caco-2 and MDCK cells migrated at molecular weights of 150 kD and 190 kD. In MDCK-MRP2 cells, the 150 kD isoform appeared to be overexpressed. MDCK-MRP2 cell monolayers exhibited higher polarized efflux of vinblastine than Caco-2 and MDCK-WT cell monolayers. K(M) values for vinblastine in Caco-2 and MDCK-MRP2 cells were determined to be 71.8+/-11.6 and 137.3+/-33.6 microM. respectively, and Vmax values were determined to be (0.54+/-0.03 and 2.45+/-0.31 pmolcm(-2)s(-1), respectively. Known substrates/inhibitors of MRP2 showed differences in their ability to inhibit vinblastine efflux in Caco-2 cells as compared to MDCK-MRP2 cells

Conclusions: These data suggest that MDCK-MRP2 cells overexpress only the 150 kD isoform of MRP2. The 190 kD isoform, which was also found in Caco-2 cells and MDCK-WT cells, was present in MDCK-MRP2 cells but not over expressed. The apparent kinetics constants and affinities of some MRP2 substrates were different in Caco-2 cells and MDCK-MRP2 cells. These differences in substrate activity could result from differences in the relative expression levels of the MRP2 isoforms present in Caco-2 cells and MDCK-MRP2 cells and/or differences in the partitioning of substrates in these two cell membrane bilayers.

Citing Articles

Knockout Transporter Cell Lines to Assess Substrate Potential Towards Efflux Transporters.

Volpe D AAPS J. 2024; 26(4):79.

PMID: 38981917 DOI: 10.1208/s12248-024-00950-6.


Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review.

Chunduri V, Maddi S ADMET DMPK. 2023; 11(1):1-32.

PMID: 36778905 PMC: 9909725. DOI: 10.5599/admet.1513.


Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients.

Gonzalez-Alvarez I, Sanchez-Dengra B, Rodriguez-Galvez R, Ruiz-Picazo A, Gonzalez-Alvarez M, Garcia-Arieta A Pharmaceutics. 2022; 14(12).

PMID: 36559059 PMC: 9783061. DOI: 10.3390/pharmaceutics14122565.


Physiologically Based Pharmacokinetic (PBPK) Modeling for Predicting Brain Levels of Drug in Rat.

Sanchez-Dengra B, Gonzalez-Alvarez I, Bermejo M, Gonzalez-Alvarez M Pharmaceutics. 2021; 13(9).

PMID: 34575476 PMC: 8471455. DOI: 10.3390/pharmaceutics13091402.


Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.

Deng F, Ghemtio L, Grazhdankin E, Wipf P, Xhaard H, Kidron H Mol Pharm. 2020; 17(7):2398-2410.

PMID: 32496785 PMC: 7497665. DOI: 10.1021/acs.molpharmaceut.0c00155.


References
1.
Ferte J . Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur J Biochem. 2000; 267(2):277-94. DOI: 10.1046/j.1432-1327.2000.01046.x. View

2.
Dietrich C, de Waart D, Ottenhoff R, Schoots I, Elferink R . Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. Mol Pharmacol. 2001; 59(5):974-80. DOI: 10.1124/mol.59.5.974. View

3.
Hosoya K, Kim K, Lee V . Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm Res. 1996; 13(6):885-90. DOI: 10.1023/a:1016005212640. View

4.
Hyafil F, Vergely C, du Vignaud P, Grand-Perret T . In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative. Cancer Res. 1993; 53(19):4595-602. View

5.
Ling V, Kartner N, Sudo T, Siminovitch L, Riordan J . Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat Rep. 1983; 67(10):869-74. View